“The projects awarded pilot studies grants for 2026 address important clinical and translational science questions,” says CTSI Director Sanjay Sethi, MD, SUNY Distinguished Professor of medicine and ...
The partners are launching ImmuneScape, a multiomics program using spatial and single-cell sequencing to study immune drivers ...
A new study led by researchers at UTHealth Houston investigated both gene expression and regulation at single cell levels to reveal disruptions in gene function in three brain regions of patients with ...
News-Medical.Net on MSN
Novel immunotherapy targeting pancreatic cancer shows promising results in phase 1/2 trial
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...
18hon MSN
AI-driven virtual screening uncovers two potent CDK9 inhibitors with anticancer effects in lab tests
A new and important discovery comes from the field of oncological research thanks to the joint work of researchers from the ...
14hon MSN
Novel immunotherapy demonstrates early potential to overcome resistance to immune checkpoint therapy
According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published in Nature Medicine, the novel monoclonal antibody linavonkibart has demonstrated the ...
The dual inhibition of PD-1 and VEGF pathways by ivonescimab aims to enhance immune response and limit tumor angiogenesis, ...
The result is one molecule that can be both a checkpoint degrader and a cancer vaccine ( Nature 2026, DOI: 10.1038/s41586-025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback